UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

Cancer, 2010-01, Vol.116 (2), p.451-458

2010

Volltextzugriff (PDF)

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Clinical cancer research, 2009-04, Vol.15 (8), p.2856-2863

2009

Volltextzugriff (PDF)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study

Journal of Nuclear Medicine, 2022-11, Vol.63 (11), p.1651-1658

2022

Volltextzugriff (PDF)

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination

European journal of radiology, 2010-03, Vol.73 (3), p.470-480

2010

Volltextzugriff (PDF)

18F‐Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma

Cancer, 2013-03, Vol.119 (6), p.1227-1234

2013

Volltextzugriff (PDF)

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria

European journal of nuclear medicine and molecular imaging, 2022-10, Vol.49 (12), p.4271-4281

2022

Volltextzugriff (PDF)

Fibroblast Activation Protein Expression in Sarcomas

Sarcoma, 2023-06, Vol.2023, p.2480493-11

2023

Volltextzugriff (PDF)

Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer

Radiology, 2023-07, Vol.308 (1), p.e222148

2023

Volltextzugriff (PDF)

Non-oncologic incidental uptake on FAPI PET/CT imaging

British journal of radiology, 2023-02, Vol.96 (1142), p.20220463

2023

Volltextzugriff (PDF)

3′‐deoxy‐3′‐[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma

Cancer, 2012-06, Vol.118 (12), p.3135-3144

2012

Volltextzugriff (PDF)

PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma

Seminars in nuclear medicine, 2021-11, Vol.51 (6), p.584-592

2021

Volltextzugriff (PDF)

Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

Radiation oncology (London, England), 2012-10, Vol.7 (1), p.185-185, Article 185

2012

Volltextzugriff (PDF)

PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [ 177 Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study

Journal of Nuclear Medicine, 2023-07, Vol.64 (7), p.1024-1029

2023

Volltextzugriff (PDF)

[ 68 Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor

Journal of Nuclear Medicine, 2024-05, Vol.65 (5), p.820-821

2024

Volltextzugriff (PDF)

Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine

Magnetic resonance imaging clinics of North America, 2016-02, Vol.24 (1), p.1-10

2016

Volltextzugriff (PDF)

PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?

Journal of Nuclear Medicine, 2024-05, Vol.65 (5), p.818-819

2024

Volltextzugriff (PDF)

Carcinoid Heart Disease

Radiology. Imaging cancer, 2024-01, Vol.6 (1), p.e230164

2024

Volltextzugriff (PDF)

Dual-energy CT of acute bowel ischemia

Abdominal radiology (New York), 2022-05, Vol.47 (5), p.1660-1683

2022

Volltextzugriff (PDF)

Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers

The Journal of nuclear medicine (1978), 2024-03, Vol.65 (3), p.438-445

2024

Volltextzugriff (PDF)

RECIP 1.0 Predicts Progression-Free Survival After [ 177 Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine, 2024-06, Vol.65 (6), p.917

2024

Volltextzugriff (PDF)

Interscanner and Intrascanner Comparison of Virtual Unenhanced Attenuation Values Derived From Twin Beam Dual-Energy and Dual-Source, Dual-Energy Computed Tomography

Investigative radiology, 2019-01, Vol.54 (1), p.1-6

2019

Volltextzugriff (PDF)

Differences and Common Ground in 177 Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers

Journal of Nuclear Medicine, 2024-03, Vol.65 (3), p.438-445

2024

Volltextzugriff (PDF)

Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer

Radiology, 2019-03, Vol.290 (3), p.702-708

2019

Volltextzugriff (PDF)

Metabolic imaging allows early prediction of response to vandetanib

Journal of Nuclear Medicine, 2011-02, Vol.52 (2), p.231-240

2011

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(110)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(55)
Science & Technology
(53)
Life Sciences & Biomedicine
(52)
Male
(32)
Female
(28)
Radiology, Nuclear Medicine & Medical Imaging
(28)
Aged
(25)
Middle Aged
(21)
Adult
(17)
Aged, 80 And Over
(15)
Oncology
(15)
Positron-Emission Tomography
(15)
Tumors
(15)
Computed Tomography
(12)
Fluorodeoxyglucose F18
(12)
Medical Imaging
(12)
Positron Emission Tomography Computed Tomography
(11)
Radiology
(11)
Radiopharmaceuticals
(11)
Retrospective Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination

18F‐Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria

Fibroblast Activation Protein Expression in Sarcomas

Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer

Non-oncologic incidental uptake on FAPI PET/CT imaging

3′‐deoxy‐3′‐[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma

PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma

Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [ 177 Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study

[ 68 Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor

Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine

PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?

Carcinoid Heart Disease

Dual-energy CT of acute bowel ischemia

Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers

RECIP 1.0 Predicts Progression-Free Survival After [ 177 Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

Interscanner and Intrascanner Comparison of Virtual Unenhanced Attenuation Values Derived From Twin Beam Dual-Energy and Dual-Source, Dual-Energy Computed Tomography

Differences and Common Ground in 177 Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers

Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer

Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial

Metabolic imaging allows early prediction of response to vandetanib

Suchergebnisse filtern